*Tentative Schedule as of September, 2020

Plenary lecture

Plenary lecture 1

Date:  November 18 (Wed) 9:00-9:50(tentative)
Speaker:  Richard J. Simpson (La Trobe University)

Plenary lecture 2 from ESACT

Date:  November 19 (Thu) 17:45-19:25(tentative)
Speakers:  Antonio Roldao (iBET & ITQB NOVA Univ. Lisbon)
Francesc Godia (Universitat Autònoma de Barcelona)

Plenary lecture 3

Date:  November 20 (Fri) 11:00-12:00(tentative)
Speaker:  Chin-Kun Wang (Chung Shan Medical University)


Symposium 1

Date:  November 17 (Tue) 9:00-11:00(tentative)

Advanced technology for biopharmaceutical production.

Organizers:  Ryuma Nagano (Kyowa Kirin Co. Ltd.), Kunihiko Kodaira (Chugai Pharmaceutical Co., Ltd.)
Speakers:  Narumi Kobayashi (Kyowa Kirin Co. Ltd.), Janice Tan (Merck Pte Ltd.),
Nobumasa Takao (Chugai Pharmaceutical Co., Ltd.), Shuichi Yamamoto (Yamaguchi University)
Outline: Demand for biopharmaceutical production with animal cell technology has been increasing with market expansion for biopharmaceuticals such as antibody drugs. To solve this issue, some advanced technologies are developing for production of biopharmaceuticals. This session will introduce the next-generation biomanufacturing upstream and downstream processes to discuss the future of the bioproduction from a scientific and industrial perspective.

Symposium 2

Date:  November 17 (Tue) 13:00-15:00(tentative)

Advanced Cell Engineering -Emerging Technologies and Future Perspectives-

Organizers:  Yoshinori Kawabe (Kyushu University), Masamichi Kamihira (Kyushu University)
Speakers:  Akira Watanabe (Kyoto University), Seiji Yamauchi (Chromocenter Inc.)
Sumihiro Koyama (Able Co. Ltd.), Masaharu Somiya (Osaka University)
Outline: Advances in single cell-based evaluation procedures and manipulation techniques have been accelerating. These technologies open new horizons for the generation of high producer clones of biopharmaceuticals and evaluation of cell function. This symposium provides insights by experts from academia and industry on the latest developments in single-cell research, current technologies for chromosome analysis, cell separation, and nanocarrier engineering for single-cell evaluation. In this symposium, we would also like to discuss future prospects and challenges on the “single cell” world with active participation of the audience.

Symposium 3

Date:  November 18 (Wed) 10:30-12:00(tentative)

Frontier science for the exosome and extracellular microparticle research by next-generation researchers (tentative)

Organizers:  Yutaka Miura (Tokyo University of Agriculture and Technology), Taichi Hara (Waseda University)
Speakers:  Yusuke Yoshioka (Tokyo Medical University), Hiroki Ida (Tohoku University),
Eisuke Itakura (Chiba University)
Outline: It is becoming clear that cellular communication through extracellular microparticles such as the exosome plays an important role in various biological regulation and disease development. This symposium will focus on exosomes and extracellular particles, and up-and-coming researchers in these research fields will introduce cutting-edge topics. We would also like to discuss the possibilities and problems of industrial application of exosomes.

Symposium 4

Date:  November 18 (Wed) 14:00-16:00(tentative)

From Basic research toward practical application

Organizers:  Shinobu Kuwae (Takeda Pharmaceutical Company), Ryuji Kato (Nagoya University),
Hiroko Tsukamoto (AGC Inc.), Hiroyuki Ijima (Kyushu University)
Speakers:  Shoen Kume (Tokyo Institute of Technology), Taro Toyoda (Kyoto University),
Yasumichi Hitoshi (Thyas Co. Ltd.), Tamihide Matsunaga (Nagoya City University)
Outline: A variety of iPS cell-derived regenerative medicines, such as retinal pigment epithelium, corneal cell sheets, and cardiomyocytes are now being investigated as clinical research and clinical trials. To widen therapeutic area application of iPS cell-derived cells, extensive researches are also being carried out in a wide variety of fields. In this symposium, insights of basic research and application research of pancreatic beta cells, as well as application of iPS cell-derived cells to cancer therapy and drug development will be provided.

Symposium 5

Date:  November 19 (Thu) 9:00-11:00(tentative)

Current issues on subvisible particles in biopharmaceuticals

Organizers:  Susumu Uchiyama (Osaka University), Kohei Tsumoto (The University of Tokyo)
Speakers:  Hiroko Shibata (National Institute of Health Sciences), Susumu Uchiyama (Osaka University),
Arni Gambe-Gilbuena (Ateneo de Manila University), Gustavo Barreto Melo (Federal University of São Paulo)
Outline: Biopharmaceuticals like antibody drugs are widely used. Micron-sized particles (subvisible particles) in biopharmaceuticals are regarded as a potential cause of immunogenicity. In this symposium, focusing on subvisible particles in biopharmaceuticals, regulatory aspect, machine learning based analysis, relation to container closure system and influence at the clinical scene of the particles will be introduced from researchers in different countries. Future perspectives on regulatory aspects, analysis and control of subvisible particles will be also discussed.

Symposium 6

Date:  November 20 (Fri) 17:00-19:00(tentative)

Cutting Edge of Food and Health Science

Organizers:  Hideo Satsu (Maebashi Institute of Technology), Tadashi Yoshida (Tokyo University of Agriculture and Technology), Tohru Koda (Kobe University)
Speakers:  Michael Krohn (B.R.A.I.N AG., Germany), Noriko M Tsuji (National Institute of Advanced Industrial Science and Technology), Hee Soon Shin (Korea Food Research Institute), Tappei Takada (The University of Tokyo)
Outline: The research for disease prevention and health promotion by food substances has been progressed in recent years. In this session, we will focus on the recent advances in food and health science. The current and future perspectives in this field will also be discussed.